SCHEMBL453206

SCHEMBL453206

CC1(C)CC(OC(=O)CCCCC(=O)OC2CC(C)(C)N(OC3CCCCC3)C(C)(C)C2)CC(C)(C)N1OC1CCCCC1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAAA Q02083 2/20 0.54
SMN1; SMN2 Q16637 1/20 0.47
KMT2A Q03164 2/20 0.39
MEN1 O00255 1/20 0.39
GAA P10253 1/20 0.39
CYP2C19 P33261 1/20 0.38
HTT P42858 1/20 0.36
EPHX2 P34913 2/20 0.35
TSHR P16473 3/20 0.34
ALDH1A1 P00352 3/20 0.33
EPHX1 P07099 1/20 0.33
KDM4E B2RXH2 1/20 0.33
LMNA P02545 1/20 0.33
HPGD P15428 1/20 0.33
ESR1 P03372 1/20 0.33
HSD17B10 Q99714 1/20 0.33
PDE3B Q13370 1/20 0.32
PDE3A Q14432 1/20 0.32
TP53 P04637 1/20 0.32
CYP19A1 P11511 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30894534 0.99 NAAA (0.56) NAAASMN1; SMN2KMT2AMEN1GAA
SCHEMBL698203 0.99 NAAA (0.56) NAAASMN1; SMN2KMT2AMEN1GAA
SCHEMBL10467609 0.99 NAAA (0.56) NAAASMN1; SMN2KMT2AMEN1GAA
SCHEMBL9743615 0.99 NAAA (0.56) NAAASMN1; SMN2KMT2AMEN1GAA
SCHEMBL30894533 0.97 NAAA (0.55) NAAASMN1; SMN2KMT2AMEN1GAA
SCHEMBL27477147 0.95 NAAA (0.49) NAAASMN1; SMN2KMT2AMEN1GAA
SCHEMBL580975 0.94 NAAA (0.45) NAAASMN1; SMN2KMT2AMEN1GAA
SCHEMBL1938967 0.94 NAAA (0.51) NAAASMN1; SMN2KMT2AMEN1GAA
SCHEMBL1232050 0.94 NAAA (0.66) NAAASMN1; SMN2KMT2AMEN1GAA
SCHEMBL20194432 0.94 NAAA (0.66) NAAASMN1; SMN2KMT2AMEN1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 610 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6391949-B1 None US claimed
US-20260146143-A1 FLAME-RETARDANT COMPOSITION, POLYMER COMPOSITION COMPRISING SAME AND USE THEREOF CLARIANT INTERNATIONAL LTD (CH) 2026-05-28 US claimed
EP-4612229-A1 FLAME-RETARDANT COMPOSITION, POLYMER COMPOSITION COMPRISING SAME AND USE THEREOF CLARIANT INTERNATIONAL LTD (CH) 2025-09-10 EP claimed
EP-3841166-B2 STABILIZED ROTOMOLDED POLYOLEFIN BASF SE (DE) 2025-05-07 EP claimed
WO-2024094455-A1 FLAME-RETARDANT COMPOSITION, POLYMER COMPOSITION COMPRISING SAME AND USE THEREOF CLARIANT INTERNATIONAL LTD (CH) 2024-05-10 WO claimed
EP-4365225-A1 FLAME-RETARDANT COMPOSITION, POLYMER COMPOSITION COMPRISING SAME AND USE THEREOF Clariant International Ltd (CH) 2024-05-08 EP claimed
EP-3565861-B1 PHOTOCURABLE HARDCOAT COMPOSITIONS, METHODS, AND ARTICLES DERIVED THEREFROM BASF SE (DE) 2023-06-21 EP claimed
US-11623979-B2 Stabilized polyolefin compositions comprising benzofuranones and hindered amine light stabilizers BASF SE (DE) 2023-04-11 US claimed
US-20230072612-A1 FLAME RETARDANT CHEMICAL COMPOSITIONS NORDTREAT FINLAND OY (FI) 2023-03-09 US claimed
EP-4097176-A1 FLAME RETARDANT CHEMICAL COMPOSITIONS Nordtreat Finland OY (FI) 2022-12-07 EP claimed
US-20020010235-A1 Polymer substrate, and a synergistic mixture of a hindered amine and a phosphorus or bromine compound. HORSEY DOUGLAS WAYNE (US) 2002-01-24 US claimed
US-20010034449-A1 Hydroxy-substituted N-Alkoxy hindered amines and compositions stabilized therewith GALBO JAMES P (US) 2001-10-25 US claimed
US-20010031872-A1 Hydroxy-substituted N-Alkoxy hindered amines and compositions stabilized therewith GALBO JAMES P (US) 2001-10-18 US claimed
US-6296674-B1 Candle wax stabilized with red-shift benzotriazoles CIBA SPECIALTY CHEMICALS CORPORATION 2001-10-02 US claimed
US-20010018520-A1 Hydroxy-substituted N-alkoxy hindered amines and compositions stabilized therewith GALBO JAMES P (US) 2001-08-30 US claimed
WO-2001057126-A1 CANDLE WAX STABILIZED BY A COMBINATION OF UV ABSORBER PLUS A SELECTED HINDERED AMINE CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2001-08-09 WO claimed
WO-2001057125-A1 CANDLE WAX STABILIZED WITH RED-SHIFTED BENZOTRIAZOLES CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2001-08-09 WO claimed
US-6221115-B1 WHITE, DYED, DIPPED, UNSCENTED AND/OR SCENTED CANDLE WAX STABILIZED BY A ULTRAVILET RADIATION ABSORBER AND HINDERED AMINE STABILIZING AGENT CIBA SPECIALTY CHEMICALS CORPORATION 2001-04-24 US claimed
US-5948836-A STERICALLY HINDERED HYDROXYLAMINE ETHER; METAL OXIDE OR HYDROXIDE, AGRICULTURAL USE CIBA SPECIALTY CHEMICALS CORPORATION (US) 1999-09-07 US claimed
US-5844026-A N,N',N''-tris{2,4-bis Hydrocarbyloxy-2,2,6,6-tetra-methylpiperidin-4-yl)alkylamino!-s-triazin-6-yl}-3,3'-ethylenediiminodipropylamines, their isomers and bridged derivatives and polymer compositions stabilized therewith CIBA SPECIALTY CHEMICALS CORPORATION (US) 1998-12-01 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260146143-A1 FLAME-RETARDANT COMPOSITION, POLYMER COMPOSITION COMPRISING SAME AND USE THEREOF FFAR3, SCO2, F7 NAAA 3590/4885SMN1; SMN2 795/4885KMT2A 2785/4885
US-20010034449-A1 Hydroxy-substituted N-Alkoxy hindered amines and compositions stabilized therewith POLH, OGG1, OGFOD1 NAAA 1325/4885SMN1; SMN2 595/4885KMT2A 617/4885
US-20010018520-A1 Hydroxy-substituted N-alkoxy hindered amines and compositions stabilized therewith POLH, OGG1, OGFOD1 NAAA 1325/4885SMN1; SMN2 595/4885KMT2A 617/4885
US-20010031872-A1 Hydroxy-substituted N-Alkoxy hindered amines and compositions stabilized therewith POLH, OGG1, OGFOD1 NAAA 1325/4885SMN1; SMN2 595/4885KMT2A 617/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.